Senior insider sale
President and COO at CG ONCOLOGY, INC. — senior position signals high conviction
$22.48M
306.74K shares
What this filing means
BELLETE AMBAW plans to sell 306.74K shares of CG ONCOLOGY, INC. valued at approximately $22.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/6/2026ACC: 0001950047-26-007736
Officer· President and COO
Since Jan 2024
306.74K
Shares to sell
$22.48M
Approx. market value
75K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/6/2026
75KTotal acquired75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/6/2026 | Stock Option Exercise Cash | 75K | — |
| Total | 75K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
25K
Market value
$1.84M
8/5/2026
—Completed
Units to sell
4.30K
Market value
$316.3K
7/29/2026
—Completed
Units to sell
50K
Market value
$3.63M
7/28/2026
—Completed
Units to sell
50K
Market value
$3.63M
7/27/2026
—Completed
Units to sell
50K
Market value
$3.59M
7/23/2026
—Completed
Units to sell
52.44K
Market value
$3.82M
7/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
75K
Market value
$5.67M
8/6/2026
Total
Units
306.74K
Value
$22.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/5/2026 | 25K | $1.84M | — | Completed |
7/29/2026 | 4.30K | $316.3K | — | Completed |
7/28/2026 | 50K | $3.63M | — | Completed |
7/27/2026 | 50K | $3.63M | — | Completed |
7/23/2026 | 50K | $3.59M | — | Completed |
7/15/2026 | 52.44K | $3.82M | — | Completed |
| Planned — Approximate Date | ||||
8/6/2026 | 75K | $5.67M | NASDAQ | Planned |
| Total | 306.74K | $22.48M | ||